Influence of autoantibodies against AT1 receptor and AGTR1 polymorphisms on candesartan-based antihypertensive regimen: results from the study of optimal treatment in hypertensive patients with anti-AT1-receptor autoantibodies trial.
暂无分享,去创建一个
Min Wang | Fen Wei | Yuhua Liao | F. Zhu | Shihui Ma | Yong Yuan | Li Feng | Yan-xiang Sun | Yu-hua Liao